The Australian & New Zealand journal of obstetrics & gynaecology
-
Aust N Z J Obstet Gynaecol · Dec 2014
Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women.
Trivalent influenza vaccine (TIV) has been recommended for pregnant women in Australia for more than a decade and funded since 2009, yet vaccination coverage remains low. Misperceptions of the safety of TIV in pregnancy have been identified as a major contributor to low vaccination rates. Ongoing safety monitoring with dissemination of results could help improve antenatal influenza vaccine uptake. ⋯ These findings support the safety of TIV in pregnant women. Mobile phone technology proved an efficient method for timely surveillance of adverse events following vaccination. The low level of AEFI observed should be reassuring to antenatal patients and their providers and help promote TIV uptake.
-
To date, there is a lack of evidence to suggest that a systematic and coordinated approach to prepregnancy care might make a difference. ⋯ These preliminary data provide some optimism that a comprehensive preconception care service may positively influence maternal and neonatal outcomes.